NB-1008

BIOLOGICAL2 trials

Sponsors

NanoBio Corporation

Conditions

Healthy Adult Volunteers

Phase 1

Safety and Immunogenicity Study of Inactivated Nasal Influenza Vaccine NB-1008

CompletedNCT01333462

NanoBio CorporationHealthy Adult Volunteers

Start: 2009-03-31End: 2010-09-30Updated: 2011-04-12

Safety and Immunogenicity Study of Inactivated Nasal Influenza Vaccine NB-1008 Administered by Sprayer

CompletedNCT01354379

NanoBio CorporationHealthy Adult Volunteers

Start: 2011-05-31End: 2012-07-31Updated: 2013-03-28